- Investing Ideas
- Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Canadian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
20
Companies which are more than 50% undervalued based on analyst price target.
20 companies
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.02
7D
-1.1%
1Y
27.6%
Eupraxia Pharmaceuticals
Market Cap: CA$599.0m
A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.
EPRX
CA$8.68
7D
-11.4%
1Y
16.8%
Verano Holdings
Market Cap: CA$586.7m
Engages in the cannabis business in the United States.
VRNO
CA$8.05
7D
-3.9%
1Y
117.6%
Canopy Growth
Market Cap: CA$565.7m
Engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally.
WEED
CA$1.31
7D
-5.1%
1Y
-14.9%
Cresco Labs
Market Cap: CA$476.8m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.02
7D
-5.6%
1Y
36.0%
Spectral Medical
Market Cap: CA$396.1m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$1.37
7D
2.2%
1Y
69.1%
TerrAscend
Market Cap: CA$302.2m
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.
TSND
CA$0.76
7D
-6.2%
1Y
56.7%
High Tide
Market Cap: CA$268.9m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$2.99
7D
-5.1%
1Y
-12.8%
Aurora Cannabis
Market Cap: CA$231.7m
Engages in the production, distribution, and sale of cannabis products in Canada and internationally.
ACB
CA$3.64
7D
-5.0%
1Y
-41.9%
Cardiol Therapeutics
Market Cap: CA$182.1m
A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.
CRDL
CA$1.74
7D
19.2%
1Y
8.1%
Organigram Global
Market Cap: CA$173.2m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.23
7D
-12.8%
1Y
-38.5%
HLS Therapeutics
Market Cap: CA$131.4m
A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and internationally.
HLS
CA$4.16
7D
-2.8%
1Y
-15.3%
Decibel Cannabis
Market Cap: CA$66.4m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.12
7D
4.5%
1Y
27.8%
Planet 13 Holdings
Market Cap: CA$63.7m
Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.
PLTH
CA$0.18
7D
0%
1Y
-29.4%
Vext Science
Market Cap: CA$61.9m
Through its subsidiaries, engages in integrated cannabis operations in the United States.
VEXT
CA$0.25
7D
11.1%
1Y
47.1%
Sernova Biotherapeutics
Market Cap: CA$43.4m
Operates as a clinical-stage biotechnology company in Canada.
SVA
CA$0.11
7D
-15.4%
1Y
-31.3%
Optimi Health
Market Cap: CA$36.5m
Operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.
OPTI
CA$6.98
7D
6.1%
1Y
50.1%
Medicenna Therapeutics
Market Cap: CA$33.7m
A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.
MDNA
CA$0.35
7D
-6.7%
1Y
-60.2%
Rubicon Organics
Market Cap: CA$30.4m
Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.
ROMJ
CA$0.45
7D
1.1%
1Y
0%
Delivra Health Brands
Market Cap: CA$3.1m
Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.
DHB
CA$0.10
7D
-4.8%
1Y
-56.5%